Two Sigma Investments’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Two Sigma Investments’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-35,600	Closed	-$1.65M	–	3377
2023 Q2	$1.65M	Buy	35,600 +12,400	+53%	+$429K	﹤0.01%	1587
2023 Q1	$665K	Sell	23,200 -55,390	-70%	-$1.64M	﹤0.01%	2069
2022 Q4	$2.45M	Buy	+78,590	New	+$2.56M	0.01%	1211

Two Sigma Investments's DICE Position: Q3 2023 in Review

Two Sigma Investments sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 35,600 shares — an estimated $1.65M sold.

Two Sigma Investments first reported a position in DICE in Q4 2022 and held it in 3 quarters. The position peaked at $2.45M in Q4 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Two Sigma Investments reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Two Sigma Investments sold 35,600 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.65M.
Two Sigma Investments first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Two Sigma Investments's DICE Therapeutics, Inc. Common Stock position peaked at $2.45M in Q4 2022.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Two Sigma Investments's 13F filing for Q3 2023, filed 14 Nov 2023.